The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognosis value of S45F mutation of CTNNB1 in desmoid-type fibromatosis (DF): Prospective analysis of 500 consecutive patients (pts) from ALTITUDES trial.
 
Nicolas Penel
Research Funding - Bayer (Inst); Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Janssen-Cilag
Other Relationship - PharmaMar
 
Sylvie Bonvalot
No Relationships to Disclose
 
André-Michel Bimbai
No Relationships to Disclose
 
Sébastien Salas
No Relationships to Disclose
 
Francois Le Loarer
No Relationships to Disclose
 
Alexandra Meurgey
No Relationships to Disclose
 
Sophie Piperno-Neumann
Consulting or Advisory Role - Immunocore
Research Funding - MSD (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis; PharmaMar
 
Olivier Collard
No Relationships to Disclose
 
Jean Emmanuel Kurtz
Honoraria - Clovis Oncology; GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; TESARO
Travel, Accommodations, Expenses - PharmaMar; Roche; TESARO
 
Cecile Guillemet
No Relationships to Disclose
 
Christine Chevreau
No Relationships to Disclose
 
Thomas Ryckewaert
No Relationships to Disclose
 
Antoine Italiano
No Relationships to Disclose
 
Pascaline Boudou-Rouquette
No Relationships to Disclose
 
Daniel Orbach
No Relationships to Disclose
 
Axel Le Cesne
Honoraria - Bayer; PharmaMar
 
Julien Thery
No Relationships to Disclose
 
Marie-Cecile Le Deley
No Relationships to Disclose
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - AstraZeneca; Bayer; BMS; Deciphera; Ignyta; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Deciphera; Deciphera; Deciphera; Pharmamar; Roche
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); DEciphera (Inst); GlaxoSmithKline (Inst); MSD (Inst); Novartis (Inst); OSE Pharma (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Olivier Mir
Stock and Other Ownership Interests - Amplitude Surgical; Ipsen; Transgene
Honoraria - Roche
Consulting or Advisory Role - Janssen; Lilly; Lundbeck; Pfizer; Roche
Speakers' Bureau - Lilly; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Blueprint Medicines (Inst); Ipsen
Travel, Accommodations, Expenses - Pfizer; Roche